Name | 6-Chloro-2-hydroxy-9-(2',3',5'-tri-O-acetyl-b-D-ribofuranosyl)purine |
---|---|
Synonyms |
6-chloropyrazine-2-ylhydrazine
2-chloro-6-hydrazinopyridazine 2-Hydrazino-6-chlorpyrazin 2-Chloro-6-hydrazinylpyrazine 2',3',5'-triacetyl-6-chloroguanosine 6-chloro-2-hydrazinopyrazine 2-chloro-6-hydrazino-pyrazine |
Description | 6-Chloro-2-hydroxy-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C16H17ClN4O8 |
---|---|
Molecular Weight | 428.78 |
Exact Mass | 428.07300 |
PSA | 151.96000 |
LogP | 0.50920 |
Index of Refraction | 1.678 |
~97% 161923-50-8 |
Literature: Moorman, Allan R. Patent: US2003/199686 A1, 2003 ; Location in patent: Page/Page column 6 ; |
Precursor 1 | |
---|---|
DownStream 1 | |